The largest individually powered randomized trial to demonstrate superiority of endovascular
ultrasound renal denervation (uRDN) in lowering blood pressure compared with a sham procedure​


Rigorous Study Design

Significant daytime ambulatory systolic
blood pressure reduction at 2 months

Lower ABP throughout a 24-hour period in the treatment group at 2 months compared to baseline

Significant reductions in Home and Office SBP at 2 months